JP2013504751A5 - - Google Patents

Download PDF

Info

Publication number
JP2013504751A5
JP2013504751A5 JP2012528391A JP2012528391A JP2013504751A5 JP 2013504751 A5 JP2013504751 A5 JP 2013504751A5 JP 2012528391 A JP2012528391 A JP 2012528391A JP 2012528391 A JP2012528391 A JP 2012528391A JP 2013504751 A5 JP2013504751 A5 JP 2013504751A5
Authority
JP
Japan
Prior art keywords
urine
ultrafiltration
collected
marker
gottingen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012528391A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013504751A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/063475 external-priority patent/WO2011029954A2/de
Publication of JP2013504751A publication Critical patent/JP2013504751A/ja
Publication of JP2013504751A5 publication Critical patent/JP2013504751A5/ja
Pending legal-status Critical Current

Links

JP2012528391A 2009-09-14 2010-09-14 血管疾患を診断および評価するためのポリペプチドマーカー Pending JP2013504751A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09170190.4 2009-09-14
EP09170190 2009-09-14
PCT/EP2010/063475 WO2011029954A2 (de) 2009-09-14 2010-09-14 Polypeptidmarker zur diagnostik und beurteilung vaskulärer erkrankungen

Publications (2)

Publication Number Publication Date
JP2013504751A JP2013504751A (ja) 2013-02-07
JP2013504751A5 true JP2013504751A5 (cg-RX-API-DMAC7.html) 2013-10-24

Family

ID=43301867

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012528391A Pending JP2013504751A (ja) 2009-09-14 2010-09-14 血管疾患を診断および評価するためのポリペプチドマーカー

Country Status (4)

Country Link
US (2) US20120241321A1 (cg-RX-API-DMAC7.html)
EP (1) EP2478377A2 (cg-RX-API-DMAC7.html)
JP (1) JP2013504751A (cg-RX-API-DMAC7.html)
WO (1) WO2011029954A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2680198C (en) * 2007-03-07 2016-01-19 Mosaiques Diagnostics And Therapeutics Ag Process for normalizing the concentration of analytes in a urine sample
EP1972940A1 (de) * 2007-03-14 2008-09-24 mosaiques diagnostics and therapeutics AG Verfahren und Marker zur Diagnose von Nierenerkrankungen
US9404932B2 (en) * 2007-11-05 2016-08-02 Nordic Bioscience A/S Pathology biomarker assay
JP2011515672A (ja) * 2008-03-19 2011-05-19 モザイクス ダイアグノスティクス アンド セラピューティクス アーゲー 腎尿細管の損傷および疾患の診断のための方法およびマーカー
WO2010031822A1 (de) * 2008-09-17 2010-03-25 Mosaiques Diagnostics And Therapeutics Ag Nierenzellkarzinom
WO2013150132A2 (de) * 2012-04-05 2013-10-10 Mosaiques Diagnostics And Therapeutics Ag Polypeptidmarker zur diagnostik und beurteilung von schlaganfällen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001246679B2 (en) 2000-03-30 2005-12-22 Orde Levinson Urination apparatus
DE10021737C2 (de) 2000-05-04 2002-10-17 Hermann Haller Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird
SG170009A1 (en) * 2005-11-30 2011-04-29 Mosaiques Diagnostics & Therap Polypeptide markers for the diagnosis and evaluation of vascular diseases
DK2447275T3 (en) * 2006-07-13 2015-06-29 Univ Iowa Res Found Methods and reagents for the treatment of age-related macular degeneration

Similar Documents

Publication Publication Date Title
JP7815199B2 (ja) 腎疾患及び歯周疾患を検出及び診断するための方法及び組成物
McIntyre et al. Antiphospholipid antibodies: discovery, definitions, detection and disease
ES2668863T3 (es) Péptidos, dispositivos y métodos para la detección de anticuerpos de Ehrlichia
JP2010513506A5 (cg-RX-API-DMAC7.html)
EA201070553A1 (ru) Антитела к гепцидину и варианты их применения
EA201170312A1 (ru) Селективные антитела к гепцидину-25 и их применение
JP2014517750A5 (cg-RX-API-DMAC7.html)
CN106596964B (zh) 用于诊断蠕虫感染的新型测定
JP2016526167A5 (cg-RX-API-DMAC7.html)
Jerman et al. OFD1 and flotillins are integral components of a ciliary signaling protein complex organized by polycystins in renal epithelia and odontoblasts
JP2018510213A5 (cg-RX-API-DMAC7.html)
DK2555790T3 (en) THERAPEUTIC USE OF beta-2-microglobulin
Idar et al. Purification of IgY Anti-SARS-CoV-2-Chicken Nucleocapsid and elimination of its low-temperature storage-induced aggregates
Malvoisin et al. Soluble chemokine receptor CXCR4 is present in human sera
JP6583766B2 (ja) タンパク質分離方法、タンパク質分析方法、及びタンパク質分離キット
US20130259801A1 (en) Serum amyloid p protein
AU2024303275A1 (en) Immunosorbent nanoparticles and methods of using thereof
CN101928333A (zh) 一种人eif4h多肽及其抗体制备方法
EP3707161A1 (en) Anti-trail antibodies and methods of use
WO2013125936A3 (es) Prueba de diagnóstico para enfermedades infecciosas en ganado bovino
JP2013001689A (ja) 卵黄からのIgY精製方法
Kim et al. Renal Expression of an Ammonia Transporter in Rats with a Unilateral Ureteral Obstruction
WO2018196011A1 (zh) Mfsd2a在制备诊断化脓性脑膜炎制品中的应用
TWI626248B (zh) 血紅素及肌紅素之分離方法
Afayoa et al. Haematological, biochemical and clinical changes in domestic pigs experimentally infected with African swine fever virus isolates from Uganda